DEVICE INDUSTRY COMMENTS ON FDA ELECTRONIC SIGNATURE POLICY SOUGHT
This article was originally published in The Gray Sheet
Executive SummaryDEVICE INDUSTRY COMMENTS ON FDA ELECTRONIC SIGNATURE POLICY SOUGHT by the agency in an Aug. 31 Federal Register proposed rule. FDA specifically seeks comments from device manufacturers because of an erroneous belief that a July 21, 1992 advance notice of proposed rulemaking on electronic signatures only applied to pharmaceutical manufacturers, according to FDAers. Comments on the proposed rule are due by Nov. 29.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.